Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine. Issue 12 (17th March 2015)

• Record Type: Journal Article
• Authors: Frasca, Daniela; Diaz, Alain; Romero, Maria; Landin, Ana Marie; Blomberg, Bonnie B.
• Is Part Of: Vaccine. Volume 33:Issue 12(2015)
• Page Start: 1433
• Page End: 1439
• Publication Date: 2015-03-17
• Subjects: Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2015.01.071
• Languages: English
• ISSNs: 0264-410X

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Influenza vaccination is less effective in CMV-seropositive individuals.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">B cell biomarkers of optimal vaccine responses are reduced by CMV-seropositivity.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">CMV-seropositivity is associated with increased intrinsic inflammation in B cells.</p> </list-item> </list> </p> </sec> </abstract>